Quantitative evaluation of cardiopulmonary functional reserve in pulmonary embolism patients after treatment

Background There is no research focusing on assessing cardiopulmonary functional reserve and exercise tolerance in patients with pulmonary embolism (PE) both at home and abroad, but the benefits of early exercise are well recognised. The goal of this study was to assess cardiopulmonary functional reserve in patients with PE by using the inert gas rebreathing method of cardiopulmonary exercise test (CPET), and compare with the traditional methods. Methods CPET on the bicycle ergometer were performed in 40 patients with age, gender, body mass index (BMI), systolic blood pressure, and pulmonary function matched. The first group was PE group composed of 16 PE patients (5 male, 11 female) who were given the standard antithrombotic therapy for 2 weeks. The other group was composed of 24 normal individuals (10 male, 14 female). Both the two groups were evaluated by cardiac ultrasound examination, 6 min walking test (6MWT), and CPET. Results (1) Right ventricular systolic pressure (RVSP) of PE group increased significantly than the control group ((34.81±8.15) mm Hg to (19.75±3.47) mm Hg, p 0.05; RVDD: (32.75±4.19) mm to (31.06±4.12) mm, p>0.05). 6 min walk distance was significantly reduced in patients with PE compared with normal subjects ((447.81±79.20) m to (513.75±31.45) m, p 2 AT and VO 2 peak were significantly decreased in patients with PE compared with controls (VO 2 AT: (9.44±3.82) ml/kg/min to (14.62±2.93) ml/kg/min, p 2 peak: (12.26±4.06) ml/kg/min to (23.46±6.15) ml/kg/min, p 2 slope was increased in patients with PE ((35.47±6.66) to (26.94±3.16), p 0.05), while peak cardiac output (peak CO) and the difference between exercise and resting cardiac output (CO) were both significantly reduced in patients with PE (peak CO: (5.97±2.25) l/min to (8.50±3.13) l/min, p 2 peak (r=0.675, p Conclusions Cardiopulmonary functional reserve was reduced in patients with PE in our study. CPET is an accurate, quantitative evaluation of cardiopulmonary functional reserve in patients with PE.